Covaris Expands truCOLLECT® Solution for Protein Analysis
News related to:Covaris · 1 min read
Covaris, a PerkinElmer company, has expanded its truCOLLECT® solution to support protein analysis in remote blood collection. The new capability, launched following the April 2026 genomics workflows launch, now allows for the collection, rehydration, and lysis of whole blood samples using Covaris' Adaptive Focused Acoustics® (AFA®) technology. This advancement aims to simplify the identification and monitoring of proteins and peptides in both research and clinical research settings.
Annemarie Watson, CEO of Covaris, highlighted the significance of this expansion.
The truCOLLECT Solution enables at-home blood collection without traditional phlebotomy. Patients provide a small finger-stick sample of about 50 µL of whole blood, which is immobilized and desiccated within the device. This allows the sample to be shipped at room temperature without a cold chain, making the process more convenient and cost-effective.
Covaris, a leader in sample preparation, develops and manufactures a portfolio of instruments, consumables, and reagents used in pre-analytical sample preparation for genomic and proteomic analysis. Using proprietary technologies, including focused acoustic energy, Covaris’ tools deliver highly accurate and reproducible results, empowering customers to make new discoveries, develop new assays, and improve bioanalytical results.
The expansion of the truCOLLECT Solution to support protein analysis underscores Covaris' commitment to advancing the field of proteomics. By integrating genomics and proteomics workflows, the company aims to streamline the research and development process, making it easier for scientists and researchers to identify and monitor complex biological markers.
In summary, Covaris has expanded its truCOLLECT® solution to support protein analysis, following its successful launch for genomics workflows in April 2026. The new capability enables the collection, rehydration, and lysis of whole blood samples, simplifying the identification and monitoring of proteins and peptides in both research and clinical settings.